Clinical Study
The Use of NeuroAiD (MLC601) in Postischemic Stroke Patients
Table 1
Baseline characteristics of MLC601-treated and -nontreated patients.
| | | MLC601
| Non-MLC601
| value |
| | Age, years | 66 ± 11 | 65 ± 12 | 0.71 | | Female, (%) | 9 (30) | 9 (30) | — | | Baseline mRS score | 3.4 ± 1.04 | 3.2 ± 1.3 | 0.083 | | Vascular distribution (%) | | | | | Left anterior circulation | 14 (47) | 15 (50) | 0.99 | | Right anterior circulation | 13 (43) | 12 (40) | 0.99 | | Posterior circulation | 3 (10) | 3 (10) | — | | Classification of the Index Stroke Based on the TOAST Criteria (%) | | | | | Large artery atherosclerosis | 18 (60) | 19 (63) | 0.99 | | Cardioembolism | 5 (17) | 4 (13) | 0.99 | | Small vessel occlusion | 7 (23) | 7 (23) | — | | Stroke of other determined etiology | 0 | 0 | — | | Stroke of undetermined etiology | 0 | 0 | — | | Risk factors (%) | | | | | Hypertension | 25 (83) | 27 (90) | 0.70 | | Diabetes | 9 (30) | 9 (30) | — | | Coronary artery disease | 8 (27) | 6 (20) | 0.76 | | Dyslipidemia | 18 (60) | 18 (60) | — | | Atrial fibrillation | 5 (17) | 4 (13) | 0.99 | | Prior stroke | 4 (13) | 6 (20) | 0.73 | | Average days to initiation of MLC601 | 44 days | — | — |
|
|
